NCT00859079View on ClinicalTrials.gov

Efficacy of GLP-1 Infusion in Comparison to an Insulin Infusion Protocol to Reach Normoglycemia Type 2 Diabetic Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

January 31, 2007

Conditions
Diabetes Mellitus Type 2Hyperglycemia
Interventions
DRUG

GLP-1

Patients received GLP-1 intravenously at a dose of 1.2 pmol/kg/min for at maximum 8 hours.

DRUG

Human regular insulin intravenously

Human regular insulin intravenously according to the Munich-registry.

Trial Locations (1)

8036

Medical University of Graz, Department for Internal Medicine, Graz

All Listed Sponsors
lead

Medical University of Graz

OTHER

NCT00859079 - Efficacy of GLP-1 Infusion in Comparison to an Insulin Infusion Protocol to Reach Normoglycemia Type 2 Diabetic Patients | Biotech Hunter | Biotech Hunter